HPC Cloud Technologies for Virtual Screening in Drug Discovery
暂无分享,去创建一个
[1] Samo Turk,et al. Novel Inhibitors of Trihydroxynaphthalene Reductase with Antifungal Activity Identified by Ligand-Based and Structure-Based Virtual Screening , 2011, J. Chem. Inf. Model..
[2] Doris M Kupfer. Cloud computing in biomedical research. , 2012, Aviation, space, and environmental medicine.
[3] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[4] R. Martell,et al. TARGET IDENTIFICATION Acceleration of Target Identification and Validation by Human Tumor Genomics , 2013 .
[5] S. Turk,et al. Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening. , 2013, European journal of medicinal chemistry.
[6] A Lavecchia,et al. Virtual screening strategies in drug discovery: a critical review. , 2013, Current medicinal chemistry.
[7] Peter J. Tonellato,et al. Biomedical Cloud Computing With Amazon Web Services , 2011, PLoS Comput. Biol..
[8] Ahmad Afsahi,et al. 10-Gigabit iWARP Ethernet: Comparative Performance Analysis with InfiniBand and Myrinet-10G , 2007, 2007 IEEE International Parallel and Distributed Processing Symposium.
[9] Gregor von Laszewski,et al. Comprehensive, open‐source resource usage measurement and analysis for HPC systems , 2014, Concurr. Comput. Pract. Exp..
[10] E. Akten,et al. Discovery of high affinity ligands for β2-adrenergic receptor through pharmacophore-based high-throughput virtual screening and docking. , 2014, Journal of molecular graphics & modelling.